A nascent but growing consumer market for brain-computer interface technology is driving the development of sleek new tools for decoding brain activity.
The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.